Currently, there are 116.44M common shares owned by the public and among those 104.27M shares have been available to trade.
The company’s stock has a 5-day price change of -8.24% and -53.23% over the past three months. DNMR shares are trading -39.01% year to date (YTD), with the 12-month market performance down to -78.55% lower. It has a 12-month low price of $0.60 and touched a high of $3.02 over the same period. DNMR has an average intraday trading volume of 784.85K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.76%, -19.27%, and -46.48% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Danimer Scientific Inc (NYSE: DNMR) shares accounts for 35.72% of the company’s 116.44M shares outstanding.
It has a market capitalization of $72.44M and a beta (3y monthly) value of 1.57. The earnings-per-share (ttm) stands at -$1.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.74% over the week and 7.22% over the month.
Analysts forecast that Danimer Scientific Inc (DNMR) will achieve an EPS of -0.23 for the current quarter, -0.22 for the next quarter and -0.55 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.26 while analysts give the company a high EPS estimate of -0.26. Comparatively, EPS for the current quarter was -0.38 a year ago. Earnings per share for the fiscal year are expected to increase by 41.70%, and 38.28% over the next financial year.
Looking at the support for the DNMR, a number of firms have released research notes about the stock. Jefferies stated their Hold rating for the stock in a research note on May 22, 2024, with the firm’s price target at $1.30-$0.80. Piper Sandler coverage for the Danimer Scientific Inc (DNMR) stock in a research note released on April 09, 2024 offered a Neutral rating with a price target of $1.25. Piper Sandler was of a view on October 12, 2022 that the stock is Overweight, while Cowen gave the stock Outperform rating on September 23, 2021, issuing a price target of $21. Jefferies on their part issued Buy rating on January 06, 2021.
